SCHEMBL26014791

SCHEMBL26014791

CC(C)Cc1ccc(C2(C(F)(F)F)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.40
PTGS2 P35354 4/20 0.40
LMNA P02545 2/20 0.40
CYP2C9 P11712 2/20 0.40
AKR1C3 P42330 2/20 0.40
CXCR1 P25024 2/20 0.40
CXCR2 P25025 2/20 0.40
ALB P02768 1/20 0.40
ESR1 P03372 1/20 0.40
ALOX5 P09917 1/20 0.40
RARB P10826 1/20 0.40
ADRB3 P13945 1/20 0.40
NFKB1 P19838 1/20 0.40
HTR2A P28223 1/20 0.40
NR1I3 Q14994 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
CXCL8 P10145 1/20 0.40
TSHR P16473 1/20 0.40
AKR1C2 P52895 1/20 0.40
BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26013616 0.80 HTR2A (0.41) LMNAHTR2ATSHRSIGMAR1
SCHEMBL19302498 0.79 SIGMAR1 (0.39) LMNASIGMAR1
SCHEMBL24196137 0.76 PDK2 (0.39) SIGMAR1
SCHEMBL26013635 0.76 CACNA1H (0.33) CYP2C9ESR1SIGMAR1PDE2A
SCHEMBL26017113 0.76 SIGMAR1 (0.33) SIGMAR1PDE2A
SCHEMBL19275237 0.76 PDE2A (0.42) CYP2C9SIGMAR1PDE2A
SCHEMBL21035484 0.76 CACNA1H (0.36) CYP2C9SIGMAR1
SCHEMBL21036238 0.76 PDK2 (0.37) CYP2C9TSHRSIGMAR1
SCHEMBL24196140 0.76 LOXL2 (0.41) SIGMAR1
SCHEMBL20763624 0.75 PTGS1 (0.40) PTGS1PTGS2LMNACYP2C9AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154291-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed